1. Home
  2. ELEV vs ELBM Comparison

ELEV vs ELBM Comparison

Compare ELEV & ELBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • ELBM
  • Stock Information
  • Founded
  • ELEV 2019
  • ELBM 2011
  • Country
  • ELEV United States
  • ELBM Canada
  • Employees
  • ELEV N/A
  • ELBM N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • ELBM Industrial Machinery/Components
  • Sector
  • ELEV Health Care
  • ELBM Miscellaneous
  • Exchange
  • ELEV Nasdaq
  • ELBM Nasdaq
  • Market Cap
  • ELEV 22.8M
  • ELBM 18.5M
  • IPO Year
  • ELEV 2021
  • ELBM N/A
  • Fundamental
  • Price
  • ELEV $0.38
  • ELBM $1.09
  • Analyst Decision
  • ELEV Hold
  • ELBM Strong Buy
  • Analyst Count
  • ELEV 6
  • ELBM 1
  • Target Price
  • ELEV $1.77
  • ELBM $2.20
  • AVG Volume (30 Days)
  • ELEV 2.0M
  • ELBM 702.0K
  • Earning Date
  • ELEV 08-05-2025
  • ELBM 08-13-2025
  • Dividend Yield
  • ELEV N/A
  • ELBM N/A
  • EPS Growth
  • ELEV N/A
  • ELBM N/A
  • EPS
  • ELEV N/A
  • ELBM N/A
  • Revenue
  • ELEV N/A
  • ELBM N/A
  • Revenue This Year
  • ELEV N/A
  • ELBM N/A
  • Revenue Next Year
  • ELEV N/A
  • ELBM N/A
  • P/E Ratio
  • ELEV N/A
  • ELBM N/A
  • Revenue Growth
  • ELEV N/A
  • ELBM N/A
  • 52 Week Low
  • ELEV $0.22
  • ELBM $0.91
  • 52 Week High
  • ELEV $3.28
  • ELBM $2.83
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 62.35
  • ELBM 54.48
  • Support Level
  • ELEV $0.38
  • ELBM $1.06
  • Resistance Level
  • ELEV $0.39
  • ELBM $1.15
  • Average True Range (ATR)
  • ELEV 0.01
  • ELBM 0.07
  • MACD
  • ELEV 0.00
  • ELBM 0.00
  • Stochastic Oscillator
  • ELEV 85.00
  • ELBM 29.63

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About ELBM Electra Battery Materials Corporation

Electra Battery Materials Corp is building North America's fully integrated, localized, and environmentally sustainable battery materials park. Electra Battery Materials is an integral part of the North American battery supply chain, providing low-carbon, sustainable, and traceable raw materials for the region's fast growing electric vehicle industry.

Share on Social Networks: